Azienda Ospedaliera V. Cervello

2 marketed ·

Quick facts

Marketed products

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Azienda Ospedaliera V. Cervello

What are Azienda Ospedaliera V. Cervello's marketed drugs?

Top marketed products include Deferiprone (DFP), PEG-IFN alpha2a or PEG-IFN alpha2b and Ribavirin.

Related